Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00775632
What this trial is testing

Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Who this might be right for
Graft Versus Host DiseaseBone Marrow Transplantation
University Health Network, Toronto 78
Testing effectiveness (Phase 2)UnknownNCT04985201
What this trial is testing

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Large-scale testing (Phase 3)Study completedNCT04712903
What this trial is testing

Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 101
Large-scale testing (Phase 3)Study completedNCT01450761
What this trial is testing

Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone

Who this might be right for
Small Cell Lung Carcinoma
Bristol-Myers Squibb 1,351
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)UnknownNCT05245994
What this trial is testing

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Who this might be right for
Lung CancerSmall Cell Lung CancerDurvalumab
Li Zhang, MD 60
Testing effectiveness (Phase 2)WithdrawnNCT00104754
What this trial is testing

Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00930696
What this trial is testing

Effects of Extensive Abdominal Lavage on Postoperative Inflammation Following Full Thickness Excision of Deep Endometriosis

Who this might be right for
Endometriosis
KU Leuven 20
Testing effectiveness (Phase 2)Study completedNCT00240097
What this trial is testing

Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)

Who this might be right for
Non-Small Cell Lung Cancer
University of Alabama at Birmingham 30
Large-scale testing (Phase 3)Study completedNCT00045162
What this trial is testing

S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 671
Testing effectiveness (Phase 2)Study completedNCT00003943
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

Who this might be right for
Carcinoma of Unknown PrimaryLung Cancer
Fox Chase Cancer Center 3
Not applicableNot Yet RecruitingNCT07648485
What this trial is testing

Clinical Performance of CAD/CAM Hard Hybrid Ceramic Inlays Versus Resin Composite Inlays in Vital Molars With Extensive Occluso-Proximal Cavities

Who this might be right for
Dental CariesCavity, DentalProximal Dental Caries
Cairo University 50
Large-scale testing (Phase 3)Looking for participantsNCT06712355
What this trial is testing

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
BioNTech SE 621
Early research (Phase 1)Ended earlyNCT00807755
What this trial is testing

Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 5
Not applicableUnknownNCT01024985
What this trial is testing

Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct

Who this might be right for
Multiple SclerosisNeuromyelitis Optica
University of Sao Paulo 40
Testing effectiveness (Phase 2)Study completedNCT02580994
What this trial is testing

Pembrolizumab in Untreated Extensive SCLC

Who this might be right for
Small Cell Lung Cancer (SCLC)
European Organisation for Research and Treatment of Cancer - EORTC 125
Testing effectiveness (Phase 2)Study completedNCT00006082
What this trial is testing

Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 38
Post-approval studies (Phase 4)Study completedNCT04775979
What this trial is testing

Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo

Who this might be right for
Vitiligo
Ain Shams University 20
Testing effectiveness (Phase 2)UnknownNCT01977235
What this trial is testing

Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Third Military Medical University 110
Not applicableEnded earlyNCT05699915
What this trial is testing

Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors

Who this might be right for
CancerImmune-related Adverse EventCardiac Abnormalities, Variable+4 more
Algemeen Ziekenhuis Maria Middelares 105
Next Page